MTOR and medulloblastoma: These results indicate that pharmacologic mTOR inhibition enhances the disruptive effects of PIK3CA knockdown on stem cell frequencies and suggest dual inhibition of PI3Kα and mTOR is required to efficiently block self-renewal capabilities of medulloblastoma CSCs.